ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 8th Annual ...
Amgen announced that Tepezza (teprotumumab [Genetical Recombination]) was approved by Japan's Ministry of Health, Labour and Welfare to treat active thyroid eye disease (TED) or TED with a high ...
Japan’s MHLF approves Padcev with Keytruda for first-line treatment of radically unresectable urothelial carcinoma: Tokyo Wednesday, September 25, 2024, 11:00 Hrs [IST] Astellas ...